Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Btw. it never ceases to amaze me how

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Investor2014 Member Profile
 
Followed By 34
Posts 15,725
Boards Moderated 0
Alias Born 11/23/16
160x600 placeholder
Clearside Biomedical, Eloxx Pharmaceuticals leads healthcare gainers; PDS Biotechnology, Sage Therapeutics among major losers Seeking Alpha - 6/15/2021 11:02:54 AM
Anavex Life outlines mechanism of ANAVEX2-73 and ANAVEX3-71 in treatment of Alzheimer's Disease Seeking Alpha - 6/14/2021 8:41:57 AM
Anavex Life Sciences Reports New Publication in Medical Journal Elucidating the Mechanism of ANAVEX®2-73 (blarcamesine) and ... GlobeNewswire Inc. - 6/14/2021 7:00:00 AM
Anavex Life Sciences Announces Exceeding of Enrollment Target for the Precision Medicine ANAVEX®2-73 (blarcamesine) Phase 2b... GlobeNewswire Inc. - 6/8/2021 7:00:00 AM
CEO's Presenting at Emerging Growth Conference Virtually Tomorrow InvestorsHub NewsWire - 6/8/2021 7:00:00 AM
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application ANAVEX®2-73 (blarcamesine) for the Treatment ... GlobeNewswire Inc. - 6/3/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2021 4:02:36 PM
Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of Directors GlobeNewswire Inc. - 5/26/2021 7:00:00 AM
CEO's Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/24/2021 7:03:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/19/2021 8:48:29 AM
Anavex Life Sciences EPS beats by $0.03 Seeking Alpha - 5/13/2021 7:11:29 AM
Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook GlobeNewswire Inc. - 5/13/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit GlobeNewswire Inc. - 5/7/2021 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2021 Second Quarter Financial Results and Business Outlook on Thursday, May 13, 2021 GlobeNewswire Inc. - 5/6/2021 7:00:00 AM
Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President for Nonclinical Development GlobeNewswire Inc. - 5/5/2021 7:00:00 AM
Anavex Life Sciences to Present at the B. Riley Securities’ Virtual Neuroscience Conference GlobeNewswire Inc. - 4/26/2021 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/12/2021 4:06:51 PM
Anavex Life Sciences Reports the Results of Review by the Independent Data Safety Monitoring Board for its Phase 2/3 Trials o... GlobeNewswire Inc. - 4/12/2021 7:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/9/2021 5:07:26 PM
Anavex Life Sciences to Present at the 20th Annual Needham Virtual Healthcare Conference GlobeNewswire Inc. - 4/8/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Upcoming World EPA - Evidence, Pricing and Access - Congress 2021 GlobeNewswire Inc. - 4/7/2021 7:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/1/2021 4:14:18 PM
DSMB recommends continuation of Anavex Life's late-stage Alzheimer’s study Seeking Alpha - 3/31/2021 7:14:03 AM
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of... GlobeNewswire Inc. - 3/31/2021 7:00:00 AM
Anavex Life Sciences Reports ANAVEX®2-73 (blarcamesine) featured as a Disease-Modifying Small Molecule in Phase 3 Clinical T... GlobeNewswire Inc. - 3/16/2021 7:00:00 AM
Investor2014   Tuesday, 02/23/21 03:43:51 AM
Re: Investor2014 post# 300107
Post # of 315536 
Btw. it never ceases to amaze me how people seems to read articles mentioning Anavex and data publications not for what they actually say, but as support for dearly held hopes and beliefs.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences